Decrease in accumulation of ultrasound contrast microbubbles in non‐alcoholic steatohepatitis

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Hepatology Research

• Publication date

  2007-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1872-034X.2007.00130.xPMID 17559420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular characterization of subgenotype A1 (subgroup Aa) of hepatitis B virus

  2007cited by this paper
• Dynamic US contrast study of the liver: Vascular and delayed parenchymal phase.

  2007cited by this paper
• Dynamic US contrast study of the liver: Vascular and delayed parenchymal phase

  2007cited by this paper
• Ultrasound contrast agent, Levovist microbubbles are phagocytosed by Kupffer cells-In vitro and in vivo studies.

  2006cited by this paper
• Non-alcoholic steatohepatitis.

  2005cited by this paper
• Interaction with leukocytes: phospholipid-stabilized versus albumin-shell microbubbles.

  2004cited by this paper
• Usefulness of contrast-enhanced ultrasonography with a new contrast mode, Agent Detection Imaging, in evaluating therapeutic response in hepatocellular carcinoma treated with radio-frequency ablation therapy.

  2004cited by this paper
• Pathologic features associated with fibrosis in nonalcoholic fatty liver disease.

  2004cited by this paper
• Differential diagnosis of hepatic nodules using delayed parenchymal phase imaging of levovist contrast ultrasound: comparative study with SPIO-MRI.

  2004cited by this paper
• Improved detection of hepatic metastases with pulse-inversion US during the liver-specific phase of SHU 508A: multicenter study.

  2003cited by this paper
• The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.

  2003cited by this paper
• Hepatic tumor detection: MR imaging and conventional US versus pulse-inversion harmonic US of NC100100 during its reticuloendothelial system-specific phase.

  2002cited by this paper
• Detection of an occult hepatocellular carcinoma using ultrasound with liver-specific microbubbles

  2002cited by this paper
• The utility of radiological imaging in nonalcoholic fatty liver disease.

  2002cited by this paper
• Efficacy of sequential use of superparamagnetic iron oxide and gadolinium in liver MR imaging.

  2002cited by this paper
• Motion - all patients with NASH need to have a liver biopsy: arguments for the motion.

  2002cited by this paper
• Effect of Superparamagnetic Iron Oxide-Enhanced MRI of the Liver With Hepatocellular Carcinoma and Hyperplastic Nodule

  2002cited by this paper
• Influence of microbubble surface charge on capillary transit and myocardial contrast enhancement.

  2002cited by this paper
• Myocardial and microcirculatory kinetics of BR14, a novel third-generation intravenous ultrasound contrast agent.

  2002cited by this paper
• Nonalcoholic steatohepatitis.

  2001cited by this paper
• Ninety patients with nonalcoholic steatohepatitis: insulin resistance, familial tendency, and severity of disease

  2001cited by this paper
• Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese.

  2001cited by this paper
• The role of Kupffer cells in non-alcoholic steatohepatitis of rats chronically fed with high-fat diet.

  2001cited by this paper
• Liver fibrosis in overweight patients.

  2000cited by this paper
• Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.

  2000cited by this paper
• Contrast agents.

  2000cited by this paper
• Noninvasive imaging of inflammation by ultrasound detection of phagocytosed microbubbles.

  2000cited by this paper
• Nonalcoholic steatohepatitis: an evolving diagnosis.

  2000cited by this paper
• Nonalcoholic steatohepatitis.

  2000cited by this paper
• Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity.

  1999cited by this paper
• Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions

  1999cited by this paper
• Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease

  1999cited by this paper
• Blood Flow Estimation with Harmonic Flash Echo Imaging

  1999cited by this paper
• Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508A: early experience.

  1999cited by this paper
• Stimulated acoustic emission in liver parenchyma with Levovist.

  1998cited by this paper
• Clinical applications of ultrasound contrast agents.

  1998cited by this paper
• High-resolution harmonic gray-scale imaging of normal and abnormal vessels and tissues in animals.

  1998cited by this paper
• Nonalcoholic fatty liver disease: assessment of variability in pathologic interpretations.

  1998cited by this paper
• Grafted poly-(ethylene glycol) on lipid surfaces inhibits protein adsorption and cell adhesion.

  1997cited by this paper
• Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis.

  1997cited by this paper
• Nonalcoholic steatohepatitis.

  1997cited by this paper
• Lipid deposition in kupffer cells after parenteral fat nutrition in rats: A biochemical and ultrastructural study

  1996cited by this paper
• Role of Kupffer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo.

  1996cited by this paper
• Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler.

  1995cited by this paper
• Nonalcoholic steatohepatitis: Tightening the morphological screws on a hepatic rambler

  1995cited by this paper
• Liposome-complement interactions in rat serum: implications for liposome survival studies.

  1994cited by this paper
• Contrast agents.

  1993cited by this paper
• Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes.

  1992cited by this paper
• Bacterial endotoxins and the liver.

  1990cited by this paper
• Serum procollagen type III peptide in chronic hepatitis B treated with recombinant interferon alfa-2b

  1990cited by this paper
• Sensitization of hepatic lipocytes by high‐fat diet to stimulatory effects of kupffer cell‐derived factors: Implication in alcoholic liver fibrogenesis

  1990cited by this paper
• Nonalcoholic steatohepatitis: a study of 49 patients.

  1989cited by this paper
• Relationship between fatty liver and subsequent development of necrosis, inflammation and fibrosis in experimental alcoholic liver disease.

  1989cited by this paper
• Ultrasonographical diagnosis of fatty liver: significance of the liver-kidney contrast.

  1983cited by this paper
• Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease.

  1980cited by this paper

• Linking gut permeability to liver steatosis: Noninvasive biomarker evaluation in MASLD patients – a prospective cross-sectional study

  2025cites this paper
• Accuracy of Non‐Invasive Imaging Techniques for the Diagnosis of MASH in Patients With MASLD: A Systematic Review

  2024cites this paper
• Association between paravertebral muscle radiological parameter alterations and non-alcoholic fatty liver disease

  2024cites this paper
• Blood endotoxin levels as biomarker of non-alcoholic fatty liver disease: a systematic review and meta-analysis.

  2022cites this paper
• Diagnosis and Staging of Pediatric Non-Alcoholic Fatty Liver Disease: Is Classical Ultrasound the Answer?

  2021cites this paper
• Clinical indicators for progression of nonalcoholic steatohepatitis to cirrhosis

  2021cites this paper
• Nonalcoholic Fatty Liver Disease

  2021cites this paper
• Prevention of non‐alcoholic steatohepatitis by long‐term exercise via the induction of phenotypic changes in Kupffer cells of hyperphagic obese mice

  2021cites this paper
• Hepatic Steatosis and Radiological, Clinical and Biological Correlation in Malnourished Children in Two Referral Hospitals in Cotonou

  2021cites this paper
• Periodontal disease–related nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: An emerging concept of oral‐liver axis

  2021cites this paper
• Biomolecular Ultrasound Imaging of Phagolysosomal Function.

  2020cites this paper
• Diagnostic accuracy of shear-wave elastography as a noninvasive biomarker of high-risk non-alcoholic steatohepatitis (NASH) in patients with non-alcoholic fatty liver disease (NAFLD)

  2020influential citation
• Changes in Function and Dynamics in Hepatic and Splenic Macrophages in Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• Diagnostic Accuracy of Shear Wave Elastography as a Non-invasive Biomarker of High-Risk Non-alcoholic Steatohepatitis in Patients with Non-alcoholic Fatty Liver Disease.

  2020cites this paper
• CEG_A_248635 305..314

  2020cites this paper
• Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population

  2020cites this paper
• Low-Density Lipoprotein (LDL)-Triglyceride and Its Ratio to LDL-Cholesterol as Diagnostic Biomarkers for Nonalcoholic Steatohepatitis.

  2020cites this paper
• Utilizing Contrast-Enhanced Ultrasound Imaging for Evaluating Fatty Liver Disease Progression in Pre-clinical Mouse Models.

  2019cites this paper
• Noninvasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

  2019cites this paper
• Accuracy of imaging methods for steatohepatitis diagnosis in non‐alcoholic fatty liver disease patients: A systematic review

  2019cites this paper
• Non-Invasive Imaging Modalities in Nonalcoholic Fatty Liver Disease: Where Do We Stand?

  2019cites this paper
• Metabolic Characteristics of a Novel Ultrasound Quantitative Diagnostic Index for Nonalcoholic Fatty Liver Disease

  2019cites this paper
• Characterizing Fatty Liver in vivo in Rabbits, Using Quantitative Ultrasound.

  2019cites this paper
• The role of pentraxine-3 and the new non-invasive methods in the diagnostics of non-alcoholic steatohepatitis

  2018cites this paper
• Ultrasonic Perfluorohexane‐Loaded Monocyte Imaging: Toward a Minimally Invasive Technique for Selective Detection of Liver Inflammation in Fatty Liver Disease

  2018cites this paper
• Application of contrast-enhanced ultrasonography of the hepatic vein for the differentiation of canine diffuse liver disease

  2018cites this paper
• Ultrasound diagnosis of hepaticfibrosis and steatosis

  2018cites this paper
• Skeletal muscle mass to visceral fat area ratio is an important determinant affecting hepatic conditions of non-alcoholic fatty liver disease

  2018cites this paper
• The diagnosis, biomarker and imaging of NASH.

  2017cites this paper
• Exercise training enhances in vivo clearance of endotoxin and attenuates inflammatory responses by potentiating Kupffer cell phagocytosis

  2017cites this paper
• High-Intensity Aerobic Exercise Improves Both Hepatic Fat Content and Stiffness in Sedentary Obese Men with Nonalcoholic Fatty Liver Disease

  2017cites this paper
• Elevation of serum alanine aminotransferase and aspartate aminotransferase enzymes level as a predictor of nonalcoholic fatty liver disease in type two diabetic patients

  2017cites this paper
• Washout Ratio in the Hepatic Vein Measured by Contrast‐Enhanced Ultrasonography to Distinguish Between Inflammatory and Noninflammatory Hepatic Disorders in Dogs

  2017cites this paper
• Non-invasive imaging techniques in assessing non-alcoholic fatty liver disease: a current status of available methods

  2017cites this paper
• Imaging Monitoring of Kupffer Cell Function and Hepatic Oxygen Saturation in Preneoplastic Changes During Cholangiocarcinogenesis

  2017cites this paper
• Malignant villous adenoma of the appendix invading the urinary bladder : a case report

  2016cites this paper
• Comparative imaging of surgical small intestinal disease in dogs: evaluation of pre-operative contrast-enhanced ultrasound, intra-operative contrast-enhanced ultrasound, and triple-phase contrast-enhanced computed tomography

  2016cites this paper
• Non-Invasive Assessment of Liver Injury in Non-Alcoholic Fatty Liver Disease: A Review of Literature.

  2016cites this paper
• Noninvasive Differentiation between Hepatic Steatosis and Steatohepatitis with MR Imaging Enhanced with USPIOs in Patients with Nonalcoholic Fatty Liver Disease: A Proof-of-Concept Study.

  2016cites this paper
• Metabolic imaging in obesity: underlying mechanisms and consequences in the whole body

  2015cites this paper
• Abdominelle Sonografie bei Patienten mit Diabetes mellitus. Teil 1: Leber

  2015cites this paper
• Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications

  2015cites this paper
• Diagnostic imaging modalities

  2015cites this paper
• Clinical features of hepatocellular carcinoma associated with nonalcoholic fatty liver disease: a review of human studies

  2015cites this paper
• Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.

  2015cites this paper
• Sonographic assessment of fatty liver: intraobserver and interobserver variability.

  2014cites this paper
• ESTUDIO DE LOS MECANISMOS PATOGÉNICOS DE LA HEPATITIS C Y SU RELACIÓN CON EL DESARROLLO DE ESTEATOSIS. EFECTO DE UN TRATAMIENTO ANTIOXIDANTE CON FLAVONOIDES

  2014cites this paper
• Diagnosis of Non-alcoholic Fatty Liver Disease

  2014cites this paper
• Nonalcoholic Fatty Liver Disease--The Clinician's Perspective.

  2014cites this paper
• Invasive and non-invasive diagnosis of cirrhosis and portal hypertension.

  2014cites this paper
• Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

  2014cites this paper
• Agricultural, Marine and Stock-Raising Fields

  2014cites this paper
• Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease.

  2014cites this paper
• 4Ps medicine of the fatty liver: the research model of predictive, preventive, personalized and participatory medicine—recommendations for facing obesity, fatty liver and fibrosis epidemics

  2014cites this paper
• Noninvasive biomarkers in non-alcoholic fatty liver disease: current status and a glimpse of the future.

  2014cites this paper
• Guidelines for Assessment and Management of Nonalcoholic Fatty Liver Disease in Indians

  2013cites this paper
• Current consensus and guidelines of contrast enhanced ultrasound for the characterization of focal liver lesions

  2013cites this paper
• Republished: Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification

  2013cites this paper
• Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.

  2013cites this paper
• Biomarkers of liver fibrosis.

  2013cites this paper
• Mucinous cystadenocarcinoma of the appendix in which contrast-enhanced ultrasonography was useful for assessing blood flow in a focal nodular lesion in the tumor cavity: A case report

  2013cites this paper
• Review article: the diagnosis of non‐alcoholic fatty liver disease – availability and accuracy of non‐invasive methods

  2013cites this paper
• Non invasive indexes for the assessment of patients with non-alcoholic fatty liver disease.

  2013cites this paper
• Non-alcoholic fatty liver disease: non-invasive investigation and risk stratification

  2013cites this paper
• What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome?

  2013cites this paper
• Noninvasive Diagnosis of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

  2013cites this paper
• Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD

  2012cites this paper
• Non-invasive Diagnosis of Fibrosis in Non-alcoholic Fatty Liver Disease.

  2012cites this paper
• Assessment of inflammation and fibrosis in non‐alcoholic fatty liver disease by imaging‐based techniques

  2012cites this paper
• NON-ALCOHOLIC FATTY LIVER DISEASE: INTROSPECTION

  2012cites this paper
• Overview and developments in noninvasive diagnosis of nonalcoholic fatty liver disease.

  2012cites this paper
• Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?

  2012cites this paper
• Decreased accumulation of ultrasound contrast in the liver of nonalcoholic steatohepatitis rat model.

  2011cites this paper
• Diagnosis and Evaluation of Nonalcoholic Fatty Liver Disease

  2011cites this paper
• Drinking Status of Heavy Drinkers Detected by Arrival Time Parametric Imaging Using Sonazoid-Enhanced Ultrasonography: Study of Two Cases

  2011cites this paper
• Which Clinical and Sonographic Parameters May Be Useful to Discriminate NASH from Steatosis?

  2011cites this paper
• 消化器疾患画像診断の進歩―マルチモダリティーによるAbdominal Imaging―

  2010cites this paper
• Differential Tissue Harmonic Imaging 超音波診断装置による脂肪肝の所見 ‐CT所見との対比による診断基準の再評価‐

  2010cites this paper
• Pharmacological and non‐pharmacological treatment of non‐alcoholic fatty liver disease

  2010cites this paper
• Three cases of angiomyolipoma: diagnostic imaging by contrast-enhanced ultrasonography

  2010cites this paper
• Crucial role of impaired Kupffer cell phagocytosis on the decreased Sonazoid‐enhanced echogenicity in a liver of a nonalchoholic steatohepatitis rat model

  2010cites this paper
• Current status and agenda in the diagnosis of nonalcoholic steatohepatitis in Japan.

  2010cites this paper
• Noninvasive investigations for non alcoholic fatty liver disease and liver fibrosis.

  2010cites this paper
• Systematic review: the diagnosis and staging of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

  2010cites this paper
• Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease

  2010cites this paper
• Nonalcoholic Fatty Liver Disease: A Review and Update

  2010influential citation
• Imaging of nonalcoholic steatohepatitis: advantages and pitfalls of ultrasonography and computed tomography.

  2009cites this paper
• Review: Current status of therapy in nonalcoholic fatty liver disease

  2009cites this paper
• Update on Non-alcoholic Fatty Liver Disease in Children

  2009cites this paper
• Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately?

  2009cites this paper
• Contrast-enhanced ultrasound in the diagnosis of liver diseases -Tracing the history and Perspective-

  2009cites this paper
• New imaging techniques for non-alcoholic steatohepatitis.

  2009cites this paper
• Diagnosis and therapy of nonalcoholic steatohepatitis.

  2008cites this paper
• Decreased phagocytic activity of Kupffer cells in a rat nonalcoholic steatohepatitis model.

  2008cites this paper
• Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities.

  2008cites this paper
• Review article: epidemiology, pathogenesis and potential treatments of paediatric non‐alcoholic fatty liver disease

  2008cites this paper